FDA Clearance Tracker · P200035-S011
OrganOx metra System
Last checked: Nov 20, 2026Latest source record: Feb 22, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 22, 2024
Approved
Time to decision
177 days
Received Aug 29, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P200035-S011
- Device name
- OrganOx metra System
- Applicant
- Organox Limited
- Applicant location
- Oxford
- Received
- Aug 29, 2023
- Decided
- Feb 22, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P200035
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for labeling modifications including the methdos and results of the OrganOx metra® WP01 Long-Term Follow-up PAS. This change is being made in response to the letter from FDA for P200035/R007 dated August 22, 2023. Based upon the information submitted, the PMA supplement is approved.
Source documents
Other decisions for Organox Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200035 · Decided Dec 9, 2021 · 512 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.